(Press-News.org) The American College of Medical Informatics (ACMI) has announced that Chris Harle, PhD, of the Indiana University Richard M. Fairbanks School of Public Health and the Regenstrief Institute will be inducted as one of 25 new fellows on November 10 in San Francisco, CA, at ceremonies during the American Medical Informatics Association (AMIA) 2024 Annual Symposium.
ACMI is a college of elected fellows who have made significant and sustained contributions to the field of biomedical informatics. Individuals who have achieved national recognition in the field and are committed to advancing the charitable, scientific, literary and educational purposed of ACMI are eligible for membership as a fellow. Each year, new fellows are elected by the voting members of ACMI and are elected for life.
“I am deeply honored to be included in this class of fellows,” said Dr. Harle, professor and chair of the Department of Health Policy and Management at the Fairbanks School and a research scientist at the Regenstrief Institute. “This fellowship reflects not just my personal achievements, but also the dedication of my research team members and the supportive environment at the Fairbanks School and Regenstrief. I look forward to continuing to contribute to the transformation of healthcare through informatics.”
Dr. Harle’s research focuses on the design, adoption, use and value of health information systems. Over the last 12 years, his research has focused on clinical decision support tools to aid primary care clinicians in chronic pain care and safe opioid prescribing. This work has led to the Chronic Pain OneSheet decision support system. OneSheet has been implemented at two major health systems, and Dr. Harle is working with the electronic health record vendor Epic to distribute OneSheet nationwide. Dr. Harle has also collaborated on many other studies at the intersection of informatics and health services research.
AMIA’s Annual Symposium is the premier medical informatics event, presenting leading-edge scientific research and more than 100 scientific sessions. The symposium presents work from across the spectrum of the informatics field – translational bioinformatics, clinical research informatics, clinical informatics, consumer health informatics and public health informatics.
The list of the 2024 inductees includes:
Adam Landman, MD, FAMIA, Mass General Brigham
Alexander Alekseyenko, PhD, FAMIA, Medical University of South Carolina
Andrea Hartzler, PhD, University of Washington
Anthony Solomonides, PhD, MSc (Math), MSc (AI), FAMIA, North Shore University Health System Research Institute
Benjamin Goldstein, PhD, Duke University
Christopher Harle, PhD, Indiana University & Regenstrief Institute
Craig Kuziemsky, PhD, MacEwan University
Curtis Cole, MD, Cornell University
Daniella Meeker, PhD, Yale School of Medicine and Yale New Haven Health System
Degui Zhi, PhD, D. Bradley McWilliams School of Biomedical Informatics at UTHealth Houston
Jaideep Vaidya, PhD, Rutgers University
Jiang Bian, PhD, University of Florida
Laurie Novak, PhD, FAMIA, Vanderbilt University Medical Center
Li Shen, PhD, University of Pennsylvania
Marina Sirota, PhD, University of California, San Francisco
Matthew Scotch, PhD, MPH, Arizona State University
Mattia Prosperi, PhD, FAMIA, University of Florida
Meliha Yetisgen, PhD, University of Washington
Metin Gurcan, PhD, Wake Forest University School of Medicine
Rui Zhang, PhD, FAMIA, University of Minnesota
Urmimala Sarkar, MD, MPH, University of California, San Francisco
William Lober, MD, University of Washington
Xiaobo Zhou, PhD, D. Bradley McWilliams School of Biomedical Informatics at UTHealth Houston
Xinxin (Katie) Zhu, MD, PhD, FAMIA, Yale School of Medicine
Yifan Peng, PhD, FAMIA, Weill Cornell Medicine
END
Regenstrief, Fairbanks researcher among 25 fellows to be inducted into American College of Medical Informatics
Chris Harle will be inducted at American Medical Informatics Association Annual Symposium
2024-10-02
ELSE PRESS RELEASES FROM THIS DATE:
Ontario Institute for Cancer Research funding aims to speed the development of new drugs for some of the most common cancers
2024-10-02
October 2, 2024, TORONTO – The Ontario Institute for Cancer Research (OICR) continues to support Ontario drug discovery research by funding high-quality investigations of new therapies for some of the most prevalent pediatric and adult cancers. These projects are tackling substantial challenges in cancer by increasing the effectiveness and availability of immunotherapies, making cancer more vulnerable to chemotherapy and developing a new drug for one of the deadliest forms of childhood brain cancer.
OICR’s Cancer Therapeutics Innovation Pipeline (CTIP) initiative is supporting three research teams ...
Trust in US Supreme Court continues to sink
2024-10-02
PHILADELPHIA – Driven by political partisanship, public trust in the U.S. Supreme Court has continued a downward slide since the court’s 2022 Dobbs decision overturning the Roe v. Wade ruling that established a constitutional right to abortion, according to a new survey by the Annenberg Public Policy Center (APPC) of the University of Pennsylvania.
More than half of Americans (56%) now disapprove of the Supreme Court, saying they trust it either “a little” or “not at all” to act in the best interest ...
Rice’s Biotech Launch Pad to lead commercialization of bioelectrical implant treatment for obesity, type 2 diabetes
2024-10-02
Rice University is part of a multiuniversity research team that has secured an award of up to $34.9 million from the Advanced Research Projects Agency for Health (ARPA-H) to accelerate the development of a bioelectronic implant designed to improve adherence for obesity and type 2 diabetes (T2D) treatment while reducing development and manufacturing costs.
Rice University’s Biotech Launch Pad will lead the commercialization effort for “Rx On-site Generation Using Electronics” (ROGUE), a self-contained, durable implantable device that houses cells engineered ...
Carnegie Mellon to lead development of implantable cell-based bioelectronic devices for patient-specific treatment and disease monitoring
2024-10-02
PITTSBURGH – A Carnegie Mellon University-led team has secured an award of up to $42 million from the Advanced Research Projects Agency for Health (ARPA-H) to accelerate the development of implantable, cell-based bioelectronic devices that deliver patient-specific therapy and monitor disease status, for conditions like hypo- and hyperthyroidism, in real time. This award is part of the ARPA-H REACT program, which supports the advancement of implantable bioelectronic devices to improve patient management of chronic diseases.
Burak ...
Case Western Reserve, Vanderbilt universities to develop incisionless prostate surgery using MRI and robotics
2024-10-02
CLEVELAND—Researchers at Case Western Reserve University and Vanderbilt University are pioneering a new approach to prostate cancer surgery by combining advanced robotics and “low-field” MRI technology.
The research aims to allow highly accurate, patient-tailored prostate cancer surgeries without the need for traditional incisions. This innovative research marks a major step in developing minimally invasive treatments for prostate cancer, with the potential to improve both safety and efficiency for patients.
The project is being funded by a new five-year, $3.7 million grant from the National Cancer Institute, part of the ...
Carnegie Mellon University secures ARPA-H award to improve adherence, lower cost of treatment for obesity and Type 2 diabetes patients
2024-10-02
PITTSBURGH – A Carnegie Mellon University-led team of researchers has secured an award of up to $34.9 million from the Advanced Research Projects Agency for Health (ARPA-H). The funds will fast track a bioelectronic implant that could radically improve treatment options and significantly reduce the cost of care for patients with obesity and Type 2 diabetes.
The award will drive the accelerated development and testing of “Rx On-site Generation Using Electronics (ROGUE),” a bioelectrical device that hosts a “living pharmacy,” consisting of engineered cells that produce biological therapy to treat Type 2 diabetes and obesity. The device will offer continuous, ...
A new injectable to prevent and treat hypoglycemia
2024-10-02
People with diabetes take insulin to lower high blood sugar. However, if glucose levels plunge too low — from taking too much insulin or not eating enough sugar — people can experience hypoglycemia, which can lead to dizziness, cognitive impairment, seizures or comas. To prevent and treat this condition, researchers in ACS Central Science report encapsulating the hormone glucagon. In mouse trials, the nanocapsules activated when blood sugar levels dropped dangerously low and quickly restored glucose levels.
Glucagon is a hormone that signals the liver to ...
Turning plants into workout supplement bio-factories
2024-10-02
It’s important to eat your veggies, but some essential vitamins and nutrients can only be found in animals, including certain amino acids and peptides. But, in a proof-of-concept study published in ACS’ Journal of Agricultural and Food Chemistry, researchers developed a method to produce creatine, carnosine and taurine — all animal-based nutrients and common workout supplements — right inside a plant. The system allows for different synthetic modules to be easily stacked together to boost production.
Plants can be surprisingly receptive when asked to produce compounds ...
Pablo Manavella appointed next Editor-In-Chief of The Plant Cell
2024-10-02
The American Society of Plant Biologists (ASPB) is excited to announce Pablo Manavella will serve as the next Editor-in-Chief of The Plant Cell. The Plant Cell is a leading international society journal that publishes novel research of special significance in plant biology, especially in the areas of cellular biology, molecular biology, biochemistry, genetics, development, and evolution.
Manavella is currently a Consejo Superior de Investigaciones Científicas (CSIC) researcher at the Institute for Mediterranean and Subtropical Horticulture (IHSM) in Málaga, Spain. He is the Principal Investigator in a lab focusing on the intricate mechanisms regulating ...
Unveiling genetic insights: how PAI-1 polymorphisms influence COVID-19 outcomes
2024-10-02
Despite global vaccination efforts, COVID-19 continues to pose significant risks, leading to severe complications and fatalities. These risks are driven by disrupted coagulation, impaired fibrinolysis, which is the process of breaking blood clots, and heightened inflammatory responses. The fibrinolytic system, crucial for maintaining balance within the coagulation cascade, relies on plasmin-mediated fibrin degradation. Plasminogen activators convert plasminogen into plasmin, an enzyme that breaks down ...
LAST 30 PRESS RELEASES:
Fecal microbiome and bile acid profiles differ in preterm infants with parenteral nutrition-associated cholestasis
The Institute of Science and Technology Austria (ISTA) receives €5 million donation for AI research
Study finds link between colorblindness and death from bladder cancer
Tailored treatment approach shows promise for reducing suicide and self-harm risk in teens and young adults
Call for papers: AI in biochar research for sustainable land ecosystems
Methane eating microbes turn a powerful greenhouse gas into green plastics, feed, and fuel
Hidden nitrogen in China’s rice paddies could cut fertilizer use
Texas A&M researchers expose hidden risks of firefighter gear in an effort to improve safety and performance
Wood burning in homes drives dangerous air pollution in winter
The Journal of Nuclear Medicine Ahead-of-Print Tip Sheet: January 23, 2026
ISSCR statement in response to new NIH policy on research using human fetal tissue (Notice NOT-OD-26-028)
Biologists and engineers follow goopy clues to plant-wilting bacteria
What do rats remember? IU research pushes the boundaries on what animal models can tell us about human memory
Frontiers Science House: did you miss it? Fresh stories from Davos – end of week wrap
Watching forests grow from space
New grounded theory reveals why hybrid delivery systems work the way they do
CDI scientist joins NIH group to improve post-stem cell transplant patient evaluation
Uncovering cancer's hidden oncRNA signatures: From discovery to liquid biopsy
Multiple maternal chronic conditions and risk of severe neonatal morbidity and mortality
Interactive virtual assistant for health promotion among older adults with type 2 diabetes
Ion accumulation in liquid–liquid phase separation regulates biomolecule localization
Hemispheric asymmetry in the genetic overlap between schizophrenia and white matter microstructure
Research Article | Evaluation of ten satellite-based and reanalysis precipitation datasets on a daily basis for Czechia (2001–2021)
Nano-immunotherapy synergizing ferroptosis and STING activation in metastatic bladder cancer
Insilico Medicine receives IND approval from FDA for ISM8969, an AI-empowered potential best-in-class NLRP3 inhibitor
Combined aerobic-resistance exercise: Dual efficacy and efficiency for hepatic steatosis
Expert consensus outlines a standardized framework to evaluate clinical large language models
Bioengineered tissue as a revolutionary treatment for secondary lymphedema
Forty years of tracking trees reveals how global change is impacting Amazon and Andean Forest diversity
Breathing disruptions during sleep widespread in newborns with severe spina bifida
[Press-News.org] Regenstrief, Fairbanks researcher among 25 fellows to be inducted into American College of Medical InformaticsChris Harle will be inducted at American Medical Informatics Association Annual Symposium







